News

Scientists at UCL have used artificial intelligence (AI) to identify three new multiple sclerosis (MS) subtypes. Researchers say these groundbreaking findings will help identify those people whose disease is more likely to progress and therefore better target treatments.

Exposure to phthalates, a class of chemicals widely used in packaging and consumer products, is known to interfere with normal hormone function and development in human and animal studies. Now researchers have found evidence linking pregnant women’s exposure to phthalates to altered cognitive outcomes in their infants.

Scientists report a new way to extract the protein and fiber from the mounds of brewer's leftover spent grain that otherwise goes to cattle feed or landfill and use it to create new types of protein sources, biofuels and more.

Using cryo-electron microscopy, scientists made the MutS protein, also known as the guardian of our genome, visible. That enabled them to describe how this protein coordinates the essential DNA repair process from beginning to end.

Lab-engineered antibodies remain the core facilitator of immunotherapies and CAR T-cell therapies. But these therapies have proved less effective against solid tumors, compared with other cancers. Now, researchers have uncovered why some of these antibody approaches appear to effectively kill cancer tumors in laboratory tests but are ineffective in clinical trials.

Researchers have discovered two new ways to induce tumor cell death which must both be triggered simultaneously by drugs to kill the majority of the tumor mass.

Researchers from the University of Nebraska Medical Center (UNMC) and the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL) have now observed the complete atomic structure of an enzyme called manganese superoxide dismutaseMnSOD, including its proton arrangements, with neutron scattering.

Nagoya University scientists in Japan have demonstrated how DNA-like molecules could have come together as a precursor to the origins of life.

Researchers have uncovered the structure of Glycine Transporter 1, it enables the uptake of glycine into neurons and acts as a neurotransmitter in the brain. This new information could open new avenues for developing therapeutics for psychiatric disorders.

A new study has concluded that when we watch a mime seemingly pull rope, climb steps or try to escape that infernal box, we don't struggle to recognize the implied objects, our minds automatically "see" them.